| Course | HCA 470 Strategic Planning and Implementation in Health Care |
|---|---|
| Topic | Topic 4 |
| Paper type | Strategic trade-off memo |
| Length | About 840 words, 2 pages |
| Format | Memo with APA 7 references |
| School | Grand Canyon University (GCU) |
| Program | BS in Health Care Administration |
| Updated | September 2026 |
Free sample paper for HCA 470 Topic 4
Memorandum
To: Strategy Committee of the Board, Ocotillo Regional Health
From: [Author Name], Director of Strategic Planning
Date: [Date]
Re: Recommended direction for diabetic foot care, the trade-offs it requires and the alternative we recommend rejecting
The Direction
We recommend that Ocotillo Regional Health build a limb preservation program led by its vascular surgeons, with an employed podiatrist, a certified wound nurse and a foot screening pathway from our primary care clinics, and that we do not add hyperbaric oxygen chambers for at least three years. The rest of this memo is about what that direction costs.
What We Give Up
First, capital. The program needs about $850,000 for a clinic build-out in the medical office building, wound care equipment and information system work. That is money the capital committee had tentatively assigned to expanding cardiac rehabilitation from 12 to 20 slots. Choosing the limb program means deferring the cardiac rehabilitation expansion by about two years, which will lengthen its waiting list, currently about five weeks.
Second, operating margin in the short term. We project an operating loss of about $420,000 in the first year and $180,000 in the second, before volume builds and before avoided inpatient amputations begin to show in the hospital's results. The program's payer mix, with 71 percent Medicare or Medicaid, means its direct revenue will not cover its cost for some time.
Third, hyperbaric revenue. Hyperbaric oxygen therapy is well reimbursed for patients who meet Medicare's coverage criteria. By not offering it, we give up a revenue stream the rival hospital's center earns and leave those patients to travel 30 miles for it.
Fourth, a market we stop trying to win by competition. We will not try to pull the podiatry group's referrals away from the rival center. Instead we will offer one of the group's younger podiatrists employment or a contract, accepting that most of the group's current referrals will stay where they are for now.
The Alternative We Recommend Rejecting
A national wound management company has offered to open and run a wound center at Ocotillo with two hyperbaric chambers at no capital cost to us, sharing revenue. It is a serious offer with real advantages: no capital outlay, an experienced operator, a program open within six months and hyperbaric therapy available locally. We recommend rejecting it in its current form for three reasons.
The first is evidence. Trials of hyperbaric oxygen for diabetic foot ulcers are mixed: one placebo-controlled trial found more ulcers healed at one year with hyperbaric oxygen (Löndahl et al., 2010), while another found that it did not reduce the need for amputation (Fedorko et al., 2016). A program whose economics depend on hyperbaric sessions would build our strategy on the treatment with the least certain benefit, rather than on revascularization and offloading, where our advantage lies.
The second is incentives. The company's standard contract pays it partly by treatment volume, including hyperbaric sessions, which rewards treating more rather than healing faster. Health care value is measured by outcomes per dollar (Porter, 2010), and a volume-based partner would pull the program the other way.
The third is access. The draft agreement allows the company to set patient acceptance criteria, which could restrict access for uninsured patients. That conflicts with our mission's commitment to care regardless of ability to pay. If the company accepted an all-payer requirement and outcome-based payment, we would reconsider the offer in year three as a way to add hyperbaric therapy to a program already built around vascular care.
Why the Trade Is Worth Making
Our own data show that county residents with diabetic foot ulcers reach Ocotillo mostly as emergencies, and last year we performed 71 amputations on county residents with diabetes. Each major amputation costs the hospital an average of about $48,000 in inpatient care and carries high mortality in the following years. If the program prevents 10 major amputations a year by year three, avoided inpatient costs alone would roughly match the program's operating loss in year two. More importantly, it is the direction our mission requires.
Risks of the Recommended Direction
The recommended direction carries risks the committee should weigh. Recruitment may take longer than planned; certified wound nurses and podiatrists are scarce in the region, and the program cannot open without them. Primary care physicians may not change their referral habits even when the clinic exists, which would leave the program underused in its first year. The Medicare Advantage plan may decline to add us to its preferred network at renewal. And the projected losses assume volume reaching about 600 visits a month by the end of year two; if volume stays at half that, the second-year loss would be closer to $400,000. A feasibility stress test of these assumptions will come to the committee before the board vote, with the point at which we would slow or stop the build.
Decision Requested
We ask the committee to endorse the direction, approve the $850,000 capital request for inclusion in next year's budget in place of the cardiac rehabilitation expansion, and authorize negotiations with the podiatry group. We will return with an implementation roadmap and a feasibility stress test before the full board vote.
References
Fedorko, L., Bowen, J. M., Jones, W., Oreopoulos, G., Goeree, R., Hopkins, R. B., & O'Reilly, D. J. (2016). Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: A prospective, double-blind, randomized controlled clinical trial. Diabetes Care, 39(3), 392-399. https://doi.org/10.2337/dc15-2001
Löndahl, M., Katzman, P., Nilsson, A., & Hammarlund, C. (2010). Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care, 33(5), 998-1003. https://doi.org/10.2337/dc09-1754
Porter, M. E. (2010). What is value in health care? New England Journal of Medicine, 363(26), 2477-2481. https://doi.org/10.1056/NEJMp1011024
HCA 470 Topic 4 instructions, in plain terms
The Topic 4 instructions in HCA-470 ask students to recommend a strategic direction and explain the trade-offs it involves. Students typically compare alternative strategies, choose one and justify it, addressing costs, risks and what the organization gives up. The assignment rewards honesty about sacrifices: capital that cannot be spent elsewhere, services that will be deferred, markets the organization stops pursuing. Rejected alternatives should be presented fairly, in their strongest form, with clear reasons for rejection. A memo to a board committee or executive is a common format, and recommendations should be supported by evidence, financial estimates and the organization's mission.
How the HCA-470 Topic 4 example is put together
The finished memo is brief about ambition and specific about cost. It states the direction in a sentence, then immediately names what the organization gives up: capital going to one service line and not another, attention leaving an established program, or a market it stops trying to hold. The rejected alternative is described at its strongest, with the case its supporters would make, before the reason it lost. That reason is tied to evidence about the market rather than to what leadership prefers, which is the whole test. Consequences for the people attached to the discontinued work are stated rather than assumed away. The last lines name the market signal that would justify the board reversing the choice.
Reading the HCA 470 Topic 4 rubric
The rubric for the trade-off memo rewards specificity about cost. Excellent memos state the direction briefly and then name what the organization gives up, in capital, operating results, services deferred and market position. Credit goes to describing the rejected alternative fairly, including its real advantages, and to rejecting it for stated reasons grounded in evidence and mission. The rubric values an honest account of the recommendation's own risks. The highest level explains why the trade is worth making, quantifies where possible and closes with a clear decision request, supported by credible research and financial reasoning. Memos that list benefits at length and treat costs in a sentence are the pattern this criterion marks down most.
Common HCA 470 Topic 4 mistakes, and how to avoid them
The defining failure on this topic is a plan with nothing rejected, which reads as a wish rather than a choice and is marked accordingly. Strategies adding three initiatives without displacing anything assume capital and attention nobody has. Directions justified by what leadership wants, rather than by evidence about the market, invert the reasoning the course is teaching. Rejected alternatives presented as obviously poor were never alternatives, and a reader can tell when the losing option was built to lose. Memos silent about the staff attached to discontinued work leave a board to discover the hardest part on its own. Choices with no reversal condition cannot be monitored, which makes them commitments rather than strategy.
Get an HCA-470 Topic 4 example written to your instructions
Send us the HCA-470 Topic 4 instructions, your rubric and the organization and evidence you are working from. We write a custom example to those criteria, with a dated direction, resources traced to what they displace, a genuine alternative argued and then rejected on evidence, and the conditions for reversal stated, back in 24 to 48 hours. The first one is free.
More HCA 470 papers and BS in Health Care Administration samples
- HCA 470 Topic 1: Mission Constraint Analysis
- HCA 470 Topic 2: Environmental Scan
- HCA 470 Topic 3: Competitive Position Analysis
- HCA 470 Topic 5: Service Line Viability Post
- HCA 470 Topic 6: Implementation Roadmap
- HCA 470 Topic 7: Feasibility Stress Test
- HCA 470 Topic 8: Strategy Measurement Plan
- HCA 240 Topic 4: Reimbursement Comparison
- HCA 465 Topic 4: Interprofessional Conflict Case
- HCA 360 Topic 4: Data Stewardship Plan
- HCA 460 Topic 4: Supply Chain Analysis
HCA 470 Topic 4 questions, answered
Why must a strategy say what stops?
Because capital, management attention and hiring capacity are all limited, and a direction that displaces nothing is being funded from nowhere. Naming the discontinuation also makes the choice testable: a reader can ask whether the thing being given up was worth less than the thing being bought. Plans without it are statements of enthusiasm.
How do I argue against an alternative fairly?
State it as its strongest supporter would, including what it would deliver and who it would satisfy, then answer it with evidence rather than assertion. An alternative described weakly tells a reader only that the writer wanted a particular answer. The reasoning that decides between two serious options is the substance of a strategic memo.
How far out should a strategy look?
Three to five years is the usual planning horizon for a health care organization, because that is roughly how long capital projects, recruitment and service line development take to show results. Anything shorter is an operating plan and belongs to management. Anything much longer outruns the reimbursement and regulatory assumptions the whole analysis rests on.
Where can I find a free HCA 470 Topic 4 sample paper?
The complete strategic trade-off memo is on this page, with the direction, what is given up, the rejected hyperbaric partnership, the risks, why the trade is worth it and the decision requested. A free model memo for your own case is available.
Why is the hyperbaric partnership rejected in HCA 470 Topic 4?
Because trial evidence for hyperbaric oxygen in diabetic foot ulcers is mixed, the partner is paid by treatment volume, and its draft terms could limit access for uninsured patients. It could be reconsidered later on all-payer, outcome-based terms.